FTC Cannot Request Shkreli’s Return Until Congress Acts


Law360 (June 3, 2021, 7:31 p.m. EDT) – A New York federal judge on Wednesday authorized the Federal Trade Commission to withdraw its financial restitution offer against disgraced pharmaceutical executive Martin Shkreli and his company, Vyera Pharmaceuticals LLC, account given the recent US Supreme Court ruling that the agency lacks the power to recover money from violators.

The defendants, whom the FTC and state antitrust authorities accused of monopolizing sales of the antiparasitic drug Daraprim since 2015, had opposed the commission’s request to withdraw. They argued that the appropriate response is partial summary judgment against the demand regarding the FTC’s offer for fair monetary relief.

But the U.S. District Judge …

Stay one step ahead

In the legal profession, information is the key to success. You need to know what’s going on with customers, competitors, practice areas, and industries. Law360 provides the intelligence you need to stay an expert and beat the competition.

  • Access to case data in articles (numbers, filings, courts, nature of prosecution, etc.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, requests, etc.
  • Create personalized alerts for specific case articles and topics and more!


Source link

Leave A Reply

Your email address will not be published.